Cardiovascular Systems (NASDAQ:CSII) Receives New Coverage from Analysts at StockNews.com

Posted by on Jun 6th, 2023

Equities research analysts at StockNews.com initiated coverage on shares of Cardiovascular Systems (NASDAQ:CSII – Get Rating) in a research report issued to clients and investors on Tuesday. The brokerage set a “hold” rating on the medical device company’s stock.

Separately, Lake Street Capital lowered Cardiovascular Systems from a “buy” rating to a “sell” rating in a research report on Thursday, February 9th.

Cardiovascular Systems Stock Performance

NASDAQ:CSII opened at $20.00 on Tuesday. The business’s 50-day moving average is $19.96 and its two-hundred day moving average is $17.35. The company has a debt-to-equity ratio of 0.08, a current ratio of 6.04 and a quick ratio of 4.92. Cardiovascular Systems has a 12 month low of $12.26 and a 12 month high of $20.57. The firm has a market capitalization of $843.96 million, a PE ratio of -20.62 and a beta of 0.74.

Institutional Trading of Cardiovascular Systems

Large investors have recently modified their holdings of the business. Water Island Capital LLC acquired a new position in Cardiovascular Systems in the first quarter worth about $31,755,000. Gabelli Funds LLC grew its stake in Cardiovascular Systems by 3,023.5% in the first quarter. Gabelli Funds LLC now owns 878,285 shares of the medical device company’s stock worth $17,443,000 after purchasing an additional 850,166 shares in the last quarter. Federated Hermes Inc. grew its stake in Cardiovascular Systems by 65.6% in the third quarter. Federated Hermes Inc. now owns 1,370,755 shares of the medical device company’s stock worth $18,999,000 after purchasing an additional 542,822 shares in the last quarter. New York Life Investment Management LLC acquired a new position in Cardiovascular Systems in the first quarter worth about $6,473,000. Finally, GABELLI & Co INVESTMENT ADVISERS INC. acquired a new position in Cardiovascular Systems in the first quarter worth about $5,776,000. 86.61% of the stock is currently owned by institutional investors and hedge funds.

About Cardiovascular Systems

(Get Rating)

Cardiovascular Systems, Inc is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St.

Featured Articles

Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.